Definitive Healthcare Corp. (DH) Stock

About Definitive Healthcare Corp.

Definitive Healthcare Corp. is led by CEO Kevin D. Coop, employs 782 people, headquartered in US, publicly traded since 2021.

Definitive Healthcare Corp. (DH) stock trades at $1.08 with a market capitalization of $115.28M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.62, reflecting a net loss over the last twelve months, price-to-book of 0.72, price-to-sales of 0.45. Over the past 52 weeks the stock has ranged between $0.61 and $3.48, and currently trades 69.0% below its 52-week high.

On profitability, Definitive Healthcare Corp. generates a return on equity (ROE) of -78.52% (negative, reflecting a net loss), return on capital employed of 42.63%, an operating margin of 66.89%, a net profit margin of -72.28%.

Definitive Healthcare Corp. by the numbers, 2019–2025

Between 2019 and 2025 Definitive Healthcare Corp. reported revenue of $86.0M rising to $242.0M, a change of +181.4% across 7 years. Compounded, revenue has grown 15.4% a year over five years, 2.8% over three, -4.0% over the last twelve months. Net profit fell to $-139.0M.

Operating margin went from -2.5% in 2019 to -8.5% in 2025, a fall of 6.0 percentage points. The most recent net margin is -72.28%. On a trailing twelve-month basis to Jun '26, revenue is $233.0M and net profit $-168.0M.

Borrowings fell from $439.0M to $173.0M, cash from operations was $54.0M in the latest year, positive in 7 of the last 7.

Return on equity has averaged -34.5% over five years, and was -49.5% in the most recent year.

The share price itself has compounded at —% a year over five years, -57.9% over three, -78.0% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Definitive Healthcare Corp. (DH) — frequently asked questions